12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Fri, 04 Apr 2025 13:16:57 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Server: cloudflare [5] => Nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800} [6] => Vary: Accept-Encoding [7] => X-Powered-By: PHP/7.4.33 [8] => Cache-Control: no-cache, private [9] => Cf-Ray: 92b1154a1b5c08d4-LAX [10] => X-Frame-Options: SAMEORIGIN [11] => X-Xss-Protection: 1; mode=block [12] => X-Content-Type-Options: nosniff [13] => Referrer-Policy: no-referrer-when-downgrade [14] => Cf-Cache-Status: DYNAMIC [15] => Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=4v2AqxJBAOtJ0zfYNytaIsJdz1Qaptc6lB4wYZiDcmWEFR7YVN6C9qNdgPJUDjsdy3aez8gjauz5KBj7Wmfqtd8PMXAbD9jcmcY05jQDfYhTArng3sVaWdMhC1Mwi%2BFQ8Ic%3D"}],"group":"cf-nel","max_age":604800} [16] => Set-Cookie: UpalLiveSession=eyJpdiI6IjhVcGRVXC95RlIrY1dJT3VsOEMyTGVBPT0iLCJ2YWx1ZSI6IkFaRW0zeXp1SzBCVEt2cUFLd0o3dU5FdXJZQ1Z6aHlaN0hzSEVTRWxCZlQrVWY2c0F3eWJwUVBNRzF6NWF6ZU1QdnhFMXJlbldKN0R0ZkJRT21pcVJ3PT0iLCJtYWMiOiJlYjY0MWQ4NGFjZGFlMzJmMDlkODQwZTgwZDU3ODhjNDc2N2VhYjU3MTRlNDRjMzVmMTE3MTEyYTRhMDhjZjc4In0%3D; HttpOnly; Path=/; Max-Age=94608000; Expires=Mon, 03 Apr 2028 12:39:53 GMT [17] => alt-svc: h3=":443"; ma=86400 [18] => server-timing: cfL4;desc="?proto=TCP&rtt=187017&min_rtt=185011&rtt_var=55524&sent=5&recv=6&lost=0&retrans=0&sent_bytes=3000&recv_bytes=756&delivery_rate=14974&cwnd=33&unsent_bytes=0&cid=b1ecdee0b964148a&ts=981&x=0" ) 789

世界卫生组织会议的联席主持人周三表示，中国科学家正在测试两种针对2019年新型冠状病毒（COVID-19）的抗病毒药物，初步临床试验结果将在几周后公布。

根据路透社报道，前世卫组织病毒学家玛丽保罗基尼（Marie-Paule Kieny）博士与其他人共同主持了在日内瓦举行的为期2天的闭门研究论坛，有300多名科学家和研究人员参加，其中一些中国内地和台湾的科学家通过视讯参与了会议。

她周三在新闻发布会上透露，很多病人已经服用了抗病毒药物利托那韦（ritonavir）和洛匹那韦（lopinavir）联合干扰素，但是她没有确切的数据。

---

// // // //